Defining conversion therapy for esophageal squamous cell carcinoma

• Satoru Matsuda,
• Takahiro Tsushima,
• Ken Kato,
• Chih‐Hung Hsu,
• Jang Ming Lee,
• Ian Yu‐Hong Wong,
• Hu‐Lin Christina Wang,
• Chang Hyun Kang,
• Xufeng Guo,
• Shun Yamamoto,
• Takayuki Tsuji,
• Hirofumi Kawakubo,
• Hiroya Takeuchi,
• Simon Law,
• Yuko Kitagawa

Affiliations

Satoru Matsuda

Deepartment of Surgery Keio University School of Medicine Tokyo Japan

Takahiro Tsushima

Division of Gastrointestinal Oncology Shizuoka Cancer Center Shizuoka Japan

Ken Kato

Department of Head and Neck, Esophageal Medical Oncology National Cancer Center Hospital Tokyo Japan

Chih‐Hung Hsu

Division of Medical Oncology, Department of Oncology National Taiwan University Hospital Taipei Taiwan

Jang Ming Lee

Department of Surgery National Taiwan University Hospital Taipei Taiwan

Ian Yu‐Hong Wong

Department of Surgery, School of Clinical Medicine The University of Hong Kong Hong Kong China

Hu‐Lin Christina Wang

Division of Traumatology Far Eastern Memorial Hospital Taipei Taiwan

Chang Hyun Kang

Department of Thoracic and Cardiovascular Surgery Seoul National University Hospital Seoul Korea

Xufeng Guo

Department of Thoracic Surgery, Shanghai Chest Hospital Shanghai Jiao Tong University Shanghai China

Shun Yamamoto

Department of Head and Neck, Esophageal Medical Oncology National Cancer Center Hospital Tokyo Japan

Takayuki Tsuji

Deepartment of Surgery Keio University School of Medicine Tokyo Japan

Hirofumi Kawakubo

Deepartment of Surgery Keio University School of Medicine Tokyo Japan

Hiroya Takeuchi

Department of Surgery Hamamatsu University School of Medicine Hamamatsu Japan

Simon Law

Department of Surgery, School of Clinical Medicine The University of Hong Kong Hong Kong China

Yuko Kitagawa

Deepartment of Surgery Keio University School of Medicine Tokyo Japan